Case study: night compression use in a patient with Milroy's disease
Ambreen Chohan1, Simon Sumner2, Mairi Olivier2
1Senior Research Fellow, Allied Health Research Unit, University of Central Lancashire, Preston.
Summary
This study shows a new compression garment improved tissue oxygenation in a patient with primary lymphoedema while sitting. This adjustable garment may enhance tissue health and support 24-hour self-management for lymphoedema patients.
Area of Science:
- Vascular Medicine
- Tissue Physiology
- Compression Therapy
Background:
- Lymphoedema management requires supporting tissue health through compression.
- Dysfunctional lymphatics, fibrosis, and inflammation characterize lymphoedema.
- Effective 24-hour self-management is crucial for patients with lymphoedema.
Observation:
- A case study evaluated an adjustable compression garment on a patient with primary lymphoedema (Milroy's disease).
- Tissue oxygenation (StO2) was measured in chair-sitting and long-sitting positions.
- Measurements were taken before, during, and after a 20-minute application of the new garment.
Findings:
- In the chair-sitting position, StO2 increased significantly from 52% to 92% during application.
- In the long-sitting position, StO2 remained high (94.5% to 94.1%) with the garment.
- The garment maintained the efficacy of the patient's usual compression hosiery in the long-sitting position.
Implications:
- This adjustable compression garment shows potential for improving tissue oxygenation in lymphoedema.
- It may offer a viable night compression solution for enhanced self-management.
- Further research could validate its role in improving tissue health for lymphoedema patients.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
31
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
31
Mitral Stenosis IV: Nursing Management
35
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
35
Cardiomyopathy IV: Restrictive Cardiomyopathy
23
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
Peripheral Artery Disease IV: Nursing Management
42
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
42
Mitral Stenosis III: Medical Management
20
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
20


